Pharmacovigilance activities are paramount for assessing how effectively pharmaceutical companies are deploying their resources to optimize their clinical operational performance while remaining compliant with internal procedures and regulatory guidelines.
EuroPharm Consulting team has conducted remote audits even before COVID-19 against the GCP and GVP regulations.
Today, statutory pharmacovigilance inspections have become more frequent, intense and wider in scope. Pharmaceutical companies are in great need for professionals that can quickly identify issues and offer effective and unequivocal solutions.
We offer an efficient and high-quality onsite or remote pharmacovigilance system audits that strongly adhere to the GVP, identifying problematic areas and prescribing comprehensive action plans to improve the quality of systems and processes.
Our clients choose us because:
Suitability: EuroPharm is committed to providing the best practice and highest quality results in all engagements with over 20 years of audit experience and numerous satisfied customers.
Capacity: EuroPharm follows meticulous approach for supervision and oversight of the pharmacovigilance system including documented due diligence and risk management plans.
Activity: For every client, EuroPharm reinforces the accurate documentation and efficient sharing of all defined processes and tasks, contracts and agreements to ensure quality and compliance is carried through all steps of pharmacovigilance systems.
Security: EuroPharm helps to identify needs and actions to be taken in order to maintain data integrity and management, complete safety database and prevent any losses during data transfer in line with clients business continuity plans.
Responsibility: EuroPharm ensures that client pharmacovigilance activities are appropriately supported by vendors/service providers in order to avoid the potential pharmacovigilance failures arising from outsourcing services.